Global ctDNA Sequencing Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global ctDNA Sequencing Service market size will reach US$ 1408 million by 2031.
ctDNA Sequencing Service is a high-sensitivity molecular testing technique based on liquid biopsy, designed to detect circulating tumor DNA (ctDNA) in body fluids such as blood plasma. ctDNA consists of short DNA fragments released by apoptotic or necrotic tumor cells, reflecting real-time tumor genetic alterations and evolution. This service involves cfDNA extraction from plasma, library preparation, targeted panel capture or whole-exome/genome sequencing, followed by advanced bioinformatics analysis to identify tumor-specific mutations, copy number variations, gene fusions, and methylation patterns. ctDNA sequencing is widely used in cancer early detection, drug selection, treatment monitoring, relapse prediction, and minimal residual disease assessment, making it a cornerstone of precision oncology and personalized cancer therapy.
United States market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key ctDNA Sequencing Service players cover CD Genomics, OncoDNA, TATAA Biocenter, Signios Bio, Abnova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “ctDNA Sequencing Service Industry Forecast” looks at past sales and reviews total world ctDNA Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected ctDNA Sequencing Service sales for 2025 through 2031. With ctDNA Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ctDNA Sequencing Service industry.
This Insight Report provides a comprehensive analysis of the global ctDNA Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ctDNA Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ctDNA Sequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ctDNA Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ctDNA Sequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of ctDNA Sequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
ctDNA Whole-Genome Resequencing
ctDNA Exome Sequencing
ctDNA Methylation Sequencing
ctDNA Targeted Region Sequencing
Segmentation by Application:
Detection of Early-Stage Cancer
Recurrence Prediction
Personalized Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
OncoDNA
TATAA Biocenter
Signios Bio
Abnova
Frontage
Illumina
Creative Biolabs
SEQanswers
Tempus
PacBio
Please note: The report will take approximately 2 business days to prepare and deliver.
ctDNA Sequencing Service is a high-sensitivity molecular testing technique based on liquid biopsy, designed to detect circulating tumor DNA (ctDNA) in body fluids such as blood plasma. ctDNA consists of short DNA fragments released by apoptotic or necrotic tumor cells, reflecting real-time tumor genetic alterations and evolution. This service involves cfDNA extraction from plasma, library preparation, targeted panel capture or whole-exome/genome sequencing, followed by advanced bioinformatics analysis to identify tumor-specific mutations, copy number variations, gene fusions, and methylation patterns. ctDNA sequencing is widely used in cancer early detection, drug selection, treatment monitoring, relapse prediction, and minimal residual disease assessment, making it a cornerstone of precision oncology and personalized cancer therapy.
United States market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for ctDNA Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key ctDNA Sequencing Service players cover CD Genomics, OncoDNA, TATAA Biocenter, Signios Bio, Abnova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “ctDNA Sequencing Service Industry Forecast” looks at past sales and reviews total world ctDNA Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected ctDNA Sequencing Service sales for 2025 through 2031. With ctDNA Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ctDNA Sequencing Service industry.
This Insight Report provides a comprehensive analysis of the global ctDNA Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ctDNA Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ctDNA Sequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ctDNA Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ctDNA Sequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of ctDNA Sequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
ctDNA Whole-Genome Resequencing
ctDNA Exome Sequencing
ctDNA Methylation Sequencing
ctDNA Targeted Region Sequencing
Segmentation by Application:
Detection of Early-Stage Cancer
Recurrence Prediction
Personalized Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CD Genomics
OncoDNA
TATAA Biocenter
Signios Bio
Abnova
Frontage
Illumina
Creative Biolabs
SEQanswers
Tempus
PacBio
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
119 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 ctDNA Sequencing Service Market Size by Player
- 4 ctDNA Sequencing Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global ctDNA Sequencing Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
